𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary mouse embryonic fibroblasts: A model of mesenchymal cartilage formation

✍ Scribed by Christopher J. Lengner; Christoph Lepper; Andre J. van Wijnen; Janet L. Stein; Gary S. Stein; Jane B. Lian


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
303 KB
Volume
200
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Cartilage formation is an intricate process that requires temporal and spatial organization of regulatory factors in order for a mesenchymal progenitor cell to differentiate through the distinct stages of chondrogenesis. Gene function during this process has best been studied by analysis of in vivo cartilage formation in genetically altered mouse models. Mouse embryonic fibroblasts (MEFs) isolated from such mouse models have been widely used for the study of growth control and DNA damage response. Here, we address the potential of MEFs to undergo chondrogenic differentiation. We demonstrate for the first time that MEFs can enter and complete the program of chondrogenic differentiation ex vivo, from undifferentiated progenitor cells to mature, hypertrophic chondrocytes. We show that chondrogenic differentiation can be induced by cell–cell contact or BMP‐2 treatment, while in combination, these conditions synergistically enhance chondrocyte differentiation resulting in the formation of 3‐dimensional (3‐D) cartilaginous tissue ex vivo. Temporal expression profiles of pro‐chondrogenic transcription factors Bapx1 and Sox9 and cartilaginous extracellular matrix (ECM) proteins Collagen Type II and X (Coll II and Coll X) demonstrate that the in vivo progression of chondrocyte maturation is recapitulated in the MEF model system. Our findings establish the MEF as a powerful tool for the generation of cartilaginous tissue ex vivo and for the study of gene function during chondrogenesis. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


A mouse embryonic stem cell model of Sch
✍ Therese M. Roth; Poornapriya Ramamurthy; Fumi Ebisu; Robert P. Lisak; Beverly M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

## Abstract The neurofibromatosis Type 1 (NF1) gene functions as a tumor suppressor gene. One known function of neurofibromin, the NF1 protein product, is to accelerate the slow intrinsic GTPase activity of Ras to increase the production of inactive rasGDP, with wide‐ranging effects on p21ras pathw